Puri Sentul Permai Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Puri Sentul Permai Tbk trades at Rp575 (market cap 712.51B, 812.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Puri Sentul Permai Tbk is far larger — about 4.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Puri Sentul Permai Tbk is more actively traded (812.2K versus 96.7K). Which is the better fit depends on your goals.
| KDTN | OBAT | |
|---|---|---|
Market Cap | 712.51B | 167.37B |
Volume | 812.2K | 96.7K |
Lot | 8.12K | 967 |
Turnover | 474.09M | 23.82M |
Average Price | 583.72 | 246.34 |
Value | 474.09M | 23.82M |
Indicative Equilibrium Price | 570 | 248 |
Indicative Equilibrium Volume | 5.9K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Puri Sentul Permai Tbk (“the Company”) was established on July 8, 2008 based on Notarial Deed No.28 of Ernie, S.H., Notary in Jakarta. The Company started its commercial operation since 2011.
Read more on KDTN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →